
Atzopit 4000mg/500mg Injection
Marketer
Atishya Biotech
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Atzopit 4000mg/500mg Injection
Combipac 4000mg/500mg Injection, a dual-antibiotic formulation, combats diverse bacterial infections by eliminating microorganisms. Administered solely by medical professionals, its dosage and frequency are determined by the treating physician based on individual patient needs. Strict adherence to prescribed usage is crucial. Commonly reported side effects include gastrointestinal upset (nausea, vomiting, diarrhea), skin rash, and localized injection site reactions (pain, swelling, redness). Persistent or worsening side effects warrant immediate medical consultation. Prior to treatment, disclose any antibiotic allergies, liver, or kidney issues to your doctor, who may adjust the dosage or alternative medication. While generally considered safe during pregnancy and lactation under medical guidance, professional oversight is paramount.
Uses of Atzopit 4000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Atzopit 4000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Atzopit 4000mg/500mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Atzopit 4000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Atzopit 4000mg/500mg Injection works:
The injectable formulation Atzopit 4000mg/500mg unites Piperacillin, a bacterial growth inhibitor, with Tazobactum, a beta-lactamase inhibitor. Piperacillin's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Tazobactum counters bacterial resistance, thereby amplifying Piperacillin's antibiotic effect.
SAFETY ADVICE
AlcoholSAFE
Atzopit 4000mg/500mg Injection does not produce adverse reactions when taken with alcohol.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Atzopit (4000mg/500mg) is typically deemed safe for pregnant individuals. Preclinical trials using animal models revealed minimal or absent harm to the fetus; nevertheless, clinical data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
The 4000mg/500mg Atzopit injection is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.
DrivingCONSULT YOUR DOCTOR
The impact of Atzopit 4000mg/500mg Injection on driving ability is undetermined. Refrain from driving if you exhibit any symptoms impairing concentration or reaction time.
KidneyCAUTION
The injectable formulation of Atzopit (4000mg/500mg) requires careful administration in individuals with impaired renal function. Dosage modification of Atzopit (4000mg/500mg) injection may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Atzopit 4000mg/500mg Injection in individuals with hepatic impairment is likely safe. Preliminary evidence indicates dose modification may be unnecessary. Physician consultation is recommended.
What if you forget to take Atzopit 4000mg/500mg Injection :
Should you forget a scheduled Atzopit 4000mg/500mg Injection, seek your physician's advice.
Facts to Know About Atzopit 4000mg/500mg Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Medication | Agents against infection |
